A phase I drug interactions study of omecamtiv mecarbil in volunteers.
Phase of Trial: Phase I
Latest Information Update: 07 Apr 2009
At a glance
- Drugs Omecamtiv mecarbil (Primary) ; Diltiazem; Ketoconazole
- Indications Angina pectoris; Cardiomyopathies; Heart failure
- Focus Pharmacogenomic; Pharmacokinetics
- 13 Jun 2008 Additional results in phenotype groups are expected to be reported in the second half of 2008, according to a Cytokinetics media release.
- 13 Jun 2008 Interim results data were reported in a Cytokinetics media release.
- 29 Apr 2008 Cytokinetics has reported that interim results are expected in the second half of 2008.